Ms. Russo brings with her over 15 years of vast experience as a CPA and and background in publicly-traded companies. She has an extensive knowledge in financial modelling and forecasting, IPO procedures, and a track record of improving fiscal performance, productivity, and internal controls. Most recently, Ms. Russo served as CFO of OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a pharmaceutical company, where she was in charge of all non-R&D aspects of managing business, Prior to her tenure at OWCP she was a Senior Director of Finance of Rosetta Genomics Ltd. (NASDAQ: ROSG), a molecular diagnostics company, where she was responsible for all finances aspects, and reported to the Chief Financial Officer. Ms. Russo served in various roles at Rosetta Genomics since 2008. Prior to her tenure at Rosetta Genomics, Ms. Russo was an audit manager at Ernst & Young in Israel, specializing in audits of companies from various fields, both publicly traded and privately owned American and Israeli entities, from 2004 to 2008. Ms. Russo holds a BA in Economics and Accounting, from the Ruppin Academic College.